DCM Nouvelle Limited has informed the Exchange regarding 'Machine readable copy of Audited Financial Results for the period ended 31st March, 2025'.
DCMNVL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
DCM Nouvelle Limited has filed audited financial results for Q4 and full year ended March 31, 2025, with an unmodified (clean) opinion from statutory auditor Walker Chandiok & Co LLP. Standalone revenue from operations for FY25 stood at ₹1,05,845 lakhs, marginally lower than ₹1,08,088 lakhs in FY24. However, standalone profit after tax jumped sharply to ₹2,267 lakhs in FY25 from just ₹93 lakhs in FY24, translating to EPS of ₹12.14 vs ₹0.50. For Q4 alone, standalone revenue grew about 4% to ₹27,439 lakhs with PAT of ₹714 lakhs (vs ₹593 lakhs). On a consolidated basis, the company (including its chemicals subsidiary DCM Nouvelle Specialty Chemicals Limited) reported FY25 revenue of ₹1,07,589 lakhs and a PAT of ₹602 lakhs, recovering from a ₹410 lakhs loss in FY24. The chemicals subsidiary continued to post losses (₹1,682 lakhs segment loss in FY25). Net exceptional items were a net gain of ₹466 lakhs, comprising a ₹131 lakh fire-loss charge at a godown offset by a ₹597 lakh deferred grant amortisation. Operating cash flow turned strongly positive at ₹8,232 lakhs (standalone) compared to a ₹3,492 lakh outflow last year.
Despite a small dip in top-line, profitability improved sharply on a standalone basis, driven by better margins and exceptional credits, which should be viewed positively by shareholders. However, the consolidated picture is tempered by ongoing losses in the chemicals subsidiary, and the headline gain partly relies on non-recurring items. Overall, results are largely neutral-to-mildly positive, with clean audit assurance.